Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03174925 |
Other study ID # |
IRB-23634 |
Secondary ID |
NCI-2017-00841EN |
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
January 24, 2014 |
Est. completion date |
February 13, 2019 |
Study information
Verified date |
June 2021 |
Source |
Stanford University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This clinical trial studies how well ultrasound elastography works in assessing the cancer
status of potentially malignant thyroid nodules.
Description:
PRIMARY OBJECTIVES:
Determine the utility of ultrasound elastography in evaluation of thyroid nodules being
evaluated for the presence of cancer.
Elastography measures the passages of ultrasound shear waves through tissue to gauge the
stiffness and compressibility of the tissue, collectively "tissue stiffness," and may be a
better way to image thyroid nodules. Tissue stiffness is a physiological parameter that is
being evaluated for differences between non-cancerous (benign) and cancerous thyroid nodules.
Participants will undergo elastography over the 10 minutes prior to either fine needle
aspiration of a biopsy specimen or surgical resection of the thyroid nodule. Tissue specimens
from the biopsy specimen or surgical resection will be assessed pathologically to determine
actual cancer status.